SpO2 Accuracy Comparison of Smart Sock V. 2 SpO2 to Arterial Blood CO-Oximetry
1 other identifier
interventional
11
1 country
1
Brief Summary
Pulse oximetry monitoring is considered a standard physiological measurement and is used by clinicians in everyday situations to estimate arterial oxygen saturation. There are two devices used in this investigational study: BabySat v.1.0 and Owlet Baby Care, Inc. Smart SockTM 2 (currently available over-the-counter), with specific emphasis on its pulse oximetry accuracy. The BabySat and Smart SockTM 2 are non-invasive home care devices for use with infants. The purpose of this study was to validate the SpO2 accuracy of BabySat v1.0 and Owlet Smart SockTM 2, OSS v1.1 sensors pulse oximetry, during non-motion conditions over the range of 70-100% SaO2 as compared to arterial blood samples assessed by CO-Oximetry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 17, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 17, 2017
CompletedFirst Submitted
Initial submission to the registry
August 3, 2018
CompletedFirst Posted
Study publicly available on registry
August 14, 2018
CompletedResults Posted
Study results publicly available
July 23, 2019
CompletedJuly 23, 2019
July 1, 2019
4 days
August 3, 2018
May 9, 2019
July 1, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
It Was Expected That the Accuracy Root Mean Square (ARMS) Between Measured SpO2 of Owlet Smart Sock V2 v1.1 and Reference SpO2 Would Meet the Required Specification of ARMS 3% or Lower in Non-motion Conditions for the Range of 70 - 100%
The purpose of the study was to evaluate the accuracy of the blood oxygen saturation (SpO2) at rest over the range of 70-100% compared to arterial blood samples assessed by standard methods \[Co-Oximetry\]. A standard pulse oximeter accuracy is evaluated by the Accuracy Root Mean Square (ARMS). The results of accurate performance of the oximetry system require ARMS of 3% or less in non-motion conditions for the range of 70-100% SpO2 per standard.
Acute immediate assessment of the sensor accuracy compared to CO-oximetry
Study Arms (3)
Reference CO-Oximetry
ACTIVE COMPARATORReference Co-Oximetry
Owlet BabySat v1.0
EXPERIMENTALOwlet BabySat v1.0
Owlet Smart Sock V2 v1.1
EXPERIMENTALOwlet Smart SockTM 2 , OSS v1.1 Sensor and Custom Adult Thumb Sock
Interventions
A comparative, single-center, non-randomized study to evaluate the SpO2 accuracy guidelines for pulse oximetry over the range of 70-100% SaO2 under non-motion conditions. Arterial blood sampling measured by functional SaO2 CO-Oximetry, was used as the basis for comparison with Owlet BabySat v1.0 and Owlet Smart Sock 2 sensors
Eligibility Criteria
You may qualify if:
- Adults with a minimum of 3 males and a minimum of 3 females, with the balance, made up of either.
- Subject must have the ability to understand and provide written informed consent
- Subject is 18 to 50 years of age
- At least 2 darkly pigmented subjects or 15% of the subject pool, whichever is larger
- Subject must be willing and able to comply with study procedures and duration
- Subject is a non-smoker or who have not smoked within 2 days prior to the study.
You may not qualify if:
- Subject is considered as being morbidly obese (defined as BMI \>39.5)
- Compromised circulation, injury, or physical malformation of fingers, toes, hands, ears or forehead/skull or other sensor sites which would limit the ability to test sites needed for the study
- Females who are pregnant, who are trying to get pregnant
- Smoker Subjects who have refrained will be screened for COHb levels
- Subjects with known heart or cardiovascular conditions
- Subjects with known clotting disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Owlet Baby Care, Inc.lead
- Clinimark, LLCcollaborator
Study Sites (1)
Owlet Baby Care, Inc.
Lehi, Utah, 84043, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Madison Kenley, CCRP, BS
- Organization
- Owlet Baby Care, Inc.
Study Officials
- STUDY DIRECTOR
Milena Adamian, MD
Owlet Baby Care, Inc.
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 3, 2018
First Posted
August 14, 2018
Study Start
December 13, 2017
Primary Completion
December 17, 2017
Study Completion
December 17, 2017
Last Updated
July 23, 2019
Results First Posted
July 23, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share